Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis

Forfatter(e)

Niels Lomborg & Tine Lottenburger

Reumatologisk Ambulatorium, Medicinsk Afdeling, Vejle Sygehus, Sygehus Lillebælt

Ugeskr Læger 2020;182:V03200200

Reference:

UgeskrLæger 2020;182:V03200200

Blad nummer:

4/2021

Summary:

Successful treatment of alopecia totalis with tofacitinib in a Danish patient

Niels Lomborg & Tine Lottenburger

Ugeskr Læger 2020;181:V03200200

Alopecia totalis (AT) is characterised by extensive hair loss on the scalp, and common treatments are rarely effective. Janus kinase inhibitors represent a potentially new treatment modality in AT. In this case report, AT was successfully treated with tofacitinib in a 43-year-old male patient. After six months of treatment, the patient regained all his hair, and no relapse was seen after one year of treatment.

Right side